Hyderabad, Apr 29 (IANS): The Indian Vaccine Manufacturers Association (IVMA) on Monday announced Bharat Biotech Co-Founder and Executive Chairman Dr. Krishna M Ella will be its new President for a two-year period.

Under Dr Ella's leadership, the IVMA aims to fortify collaboration between vaccine manufacturers, researchers, and policymakers to accelerate the development of new vaccines and improve production processes.

"Dr Ella’s expertise and entrepreneurial spirit are exactly what the vaccine industry needs to navigate the complex challenges of the 21st century," Dr Harshavardhan said.

"His commitment to innovation and global health equity is well known, and it will undoubtedly help lead the industry in bringing transformative advancements in vaccine innovation, research, and manufacturing capabilities of India," he added.

The IVMA's mission is to bring to the fore the Indian private-sector human vaccine manufacturer’s concerns related to the progress and profitability of the industry and streamlining regulatory pathways and matters related to audits and inspections in consultations with the national Central Drugs Standard and Control Organisation.